New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
11:58 EDTTMO, ILMNNew China rule prompts BGI to suspend trisomy testing, GenomeWeb says
BGI said a recent announcement from Chinese officials that genetic tests should be regulated has prompted the company to work with its collaborators to suspend the clinical application of its non-invasive fetal trisomy test in mainland China, according to GenomeWeb. Other providers of sequencing-based trisomy testing products, including Illumina (ILMN) and Thermo Fisher-owned (TMO) Life Technologies, declined to comment on the regulation notice, the report stated. The Fly notes that Illumina announced in January of 2010 that BGI had purchased 128 HiSeq 2000 sequencing systems. Illumina said at that time that revenue related to the sale of those instruments was expected to be recognized over the next three years. Reference Link
News For ILMN;TMO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
15:46 EDTILMNPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
January 21, 2015
10:24 EDTILMNIllumina pulls back following State of the Union address
Shares of Illumina (ILMN) rose yesterday after a biotech industry website reported that President Obama might unveil a major new genomics project during his State of the Union address last night. That speculation was backed as a possibility by an analyst at Wells Fargo ahead of last night's address. In the speech, President Obama unveiled what he called his Precision Medicine Initiative, which relies on genomics to "deliver(s) the right treatment at the right time." Obama spent far more time, however, discussing economic growth and foreign relations than healthcare. Illumina shares are down 3% to $190.64 in early trading today.
January 20, 2015
13:45 EDTILMNIllumina rises as genomics project seen being announced in State of the Union
Subscribe for More Information
11:24 EDTILMNIllumina could see headline boost from U.S. genomics project, says Wells Fargo
After biotech industry publication BioCentury said Friday that the president may announce a new genomics project to sequence up to one million human genomes as part of his State of the Union speech tonight, Wells Fargo said that it believes such an announcement could be a headline catalyst for Illumina since it would mean the U.S. needs additional sequencing capacity. However, such a project would be long-term in nature, Wells Fargo cautioned, adding that such a plan would more likely support existing Illumina growth assumptions than push those forecasts up. Shares of Illumina are up 6% to $194.85 in morning trading ahead of tonight's speech by the president.
January 13, 2015
11:09 EDTTMOThermo Fisher tracking for greater than $100M cost synergies in 2014
Subscribe for More Information
07:42 EDTTMOJPMorgan to hold a conference
33rd Annual Healthcare Conference is being held in San Francisco on January 12-15 with webcasted company presentations to begin on January 13 at 10:30 am; not all company presentations may be webcasted. Webcast Link
January 12, 2015
14:47 EDTILMNIllumina sees FY15 EPS $3.12-$3.18, consensus $3.17
Sees FY15 20% revenue growth of 20%, consensus $2.26B.
14:45 EDTILMNIllumina sees Q4 EPS 'slightly above' high end of prior view
Subscribe for More Information
14:42 EDTILMNIllumina options active on guidance
Subscribe for More Information
14:42 EDTILMNLockheed Martin, Illumina announce strategic alliance
Subscribe for More Information
14:09 EDTILMNIllumina sees FY15 revenue growth of 20%, consensus $2.26B
Guidance issued during presentation at JPMorgan Healthcare Conference.
14:08 EDTILMNIllumina sees Q4 revenue $512M, consensus $503.83M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use